Therefore, FKN/CX3CR1 may be a favorable or unfavorable prognostic factor, with evidence for anti-tumor functions primarily coming from prognostic studies, while evidence for pro-tumor function tends to be from tumor development studies. This evidence concerns the gene CX3CL1 and neoplasm.